Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probable warfarin-simvastatin interaction.

Tone Westergren1, Peder Johansson, Espen Molden

  • 1RELIS Medicines Information Centre, Health Region South, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway. tone.westergren@rikshospitalet.no

The Annals of Pharmacotherapy
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic overlap between treatment-resistant schizophrenia and smoking initiation.

The international journal of neuropsychopharmacology·2026
Same author

Prognostic relevance of β1-adrenergic receptor polymorphisms on cardiovascular outcome in patients treated with metoprolol after acute myocardial infarction - an observational study.

European journal of clinical pharmacology·2026
Same author

The 8th European Society of Pharmacogenomics and Personalized Therapy (ESPT) congress.

Pharmacogenomics·2026
Same author

Ketamine for depression - a critical perspective.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same author

Acute Liver Failure With Transient Liver Steatosis Following Multiple Hits Postoperatively in a Patient With Limb-Girdle Muscular Dystrophy: A Case Report.

Clinical case reports·2026
Same author

Pharmacokinetic recall study of Estonian Biobank participants with novel genetic variants in CYP2C19 and CYP2D6.

NPJ genomic medicine·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
Same journal

RSVpreF: A Vaccine for the Respiratory Syncytial Virus.

The Annals of pharmacotherapy·2026
Same journal

Severe Acute Hepatitis Induced by Combined Rosuvastatin and Ticagrelor Therapy Post-PCI: The Challenges of Multi-Drug DILI Diagnosis.

The Annals of pharmacotherapy·2026
Same journal

Modified vs Full Lead-in Dose Apixaban and Rivaroxaban for Treatment of Acute Venous Thromboembolism.

The Annals of pharmacotherapy·2026
Same journal

A Comparison of Phenobarbital Dosing Strategies for the Treatment of Alcohol Withdrawal Syndrome.

The Annals of pharmacotherapy·2026
See all related articles

Switching from atorvastatin to simvastatin may increase the risk of dangerous bleeding in patients taking warfarin. This case highlights the potential drug interaction between simvastatin and warfarin, necessitating careful monitoring.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Drug Interactions

Background:

  • Warfarin is a common anticoagulant used to prevent thrombosis.
  • Statins are widely prescribed for hyperlipidemia.
  • Drug interactions between anticoagulants and statins require careful consideration.

Observation:

  • An 82-year-old female on long-term warfarin therapy experienced a critical increase in her international normalized ratio (INR) after switching from atorvastatin to simvastatin.
  • The patient developed a fatal cerebral hemorrhage shortly after the INR elevation.
  • Her INR had been stable for over two years prior to the medication change.

Findings:

  • Studies suggest simvastatin, unlike atorvastatin, may interact with warfarin, potentially increasing its anticoagulant effect.

Related Experiment Videos

  • The mechanism of interaction between simvastatin and warfarin is not fully understood but may involve altered warfarin elimination.
  • The Naranjo probability scale indicated a probable link between simvastatin initiation and the warfarin-induced INR increase.

    • Implications:

    • Atorvastatin and simvastatin exhibit different interaction profiles with warfarin.
    • Clinicians must exercise caution and monitor INR closely when initiating simvastatin in patients already on warfarin therapy.
    • This case underscores the importance of individualized drug management in patients with complex medical histories.